Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Then again,

Moore could settle, there could be a decisively favorable Markman, we could win big if the T3 goes all the way to trial, license activity may finally be accurately described as a "wave," we could see a significant rise in share price, in which case I will have exited most likely at a loss and with a great deal of knowledge and some new friends that I never had before I heard of PTSC.

Good luck to all of us.

Share
New Message
Please login to post a reply